We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.07B
AUM Growth
+$304M
Cap. Flow
+$228M
Cap. Flow %
11.06%
Top 10 Hldgs %
26.72%
Holding
186
New
38
Increased
42
Reduced
61
Closed
43

Top Buys

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$29.1M
2
FUN icon
Cedar Fair
FUN
+$27.5M
3
DV icon
DoubleVerify
DV
+$26.8M
4
CNMD icon
CONMED
CNMD
+$21.8M
5
XRAY icon
Dentsply Sirona
XRAY
+$20.7M

Top Sells

Rank Stock Value
1
AAP icon
Advance Auto Parts
AAP
+$29.3M
2
NGD
New Gold Inc
NGD
+$20.9M
3
WBD icon
Warner Bros
WBD
+$20.7M
4
VRNT
Verint Systems
VRNT
+$19.9M
5
M icon
Macy's
M
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 20.05%
2 Healthcare 18.45%
3 Consumer Discretionary 15.14%
4 Materials 10.18%
5 Industrials 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCL icon
76
Stepan Co
SCL
$1.47B
$8.62M 0.42%
+180,717
New +$9.38M
IART icon
77
Integra LifeSciences
IART
$1.33B
$8.49M 0.41%
592,212
+39,998
+7% +$548K
EVTC icon
78
Evertec
EVTC
$1.77B
$8.36M 0.4%
247,541
+132,063
+114% +$4.6M
MYE icon
79
Myers Industries
MYE
$1.25B
$8.36M 0.4%
493,301
-728,254
-60% -$11.6M
BAX icon
80
Baxter International
BAX
$14.4B
$8.35M 0.4%
+366,655
New +$9.3M
EMN icon
81
Eastman Chemical
EMN
$8.39B
$8.3M 0.4%
131,690
+71,794
+120% +$5.01M
WBD icon
82
Warner Bros
WBD
$67.4B
$7.99M 0.39%
409,365
-1,517,869
-79% -$20.7M
QTRX icon
83
Quanterix
QTRX
$114M
$7.56M 0.37%
1,393,005
+248,101
+22% +$1.32M
ASH icon
84
Ashland
ASH
$3.45B
$7.07M 0.34%
147,482
+71,044
+93% +$3.73M
AVA icon
85
Avista
AVA
$3.2B
$7.01M 0.34%
+185,510
New +$6.9M
EGHT icon
86
8x8 Inc
EGHT
$324M
$6.7M 0.32%
3,160,713
-168,940
-5% -$340K
GETY icon
87
Getty Images
GETY
$186M
$6.52M 0.32%
3,291,027
-175,905
-5% -$326K
OVV icon
88
Ovintiv
OVV
$17.6B
$6.51M 0.32%
161,332
-11,136
-6% -$454K
PRAA icon
89
PRA Group
PRAA
$714M
$6.42M 0.31%
415,481
+53,068
+15% +$859K
B
90
Barrick Mining
B
$68.5B
$6.39M 0.31%
194,931
-79,901
-29% -$2.02M
KRNT icon
91
Kornit Digital
KRNT
$778M
$6.36M 0.31%
+470,781
New +$8M
DCH
92
Dauch Corp
DCH
$1.58B
$6.24M 0.3%
1,038,897
-320,410
-24% -$1.72M
ALIT icon
93
Alight
ALIT
$394M
$6.21M 0.3%
+95,255
New +$8.42M
ZEUS
94
DELISTED
Olympic Steel
ZEUS
$6.19M 0.3%
+203,312
New +$6.67M
FFWM
95
DELISTED
First Foundation Inc
FFWM
$6.16M 0.3%
1,106,415
-83,785
-7% -$462K
ASIX icon
96
AdvanSix
ASIX
$439M
$6.05M 0.29%
+312,371
New +$6.57M
VSTS icon
97
Vestis
VSTS
$1.83B
$5.81M 0.28%
1,282,039
+785,667
+158% +$4.03M
OLN icon
98
Olin
OLN
$2.15B
$5.76M 0.28%
+230,545
New +$5.12M
CXW icon
99
CoreCivic
CXW
$3.26B
$5.13M 0.25%
252,230
-59,367
-19% -$1.23M
ALGN icon
100
Align Technology
ALGN
$12.5B
$5.05M 0.24%
40,356
+8,169
+25% +$1.28M
2 3
4
5 6

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Invenomic Capital Management held 186 positions worth $2.07B, up 17% from $1.76B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Invenomic Capital Management deployed $228M of net new capital in Q3 2025, opening 38 new positions and adding to 42 existing holdings. Its largest new stake was Cedar Fair: 1,034,288 shares worth $23.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Warner Bros, an estimated $20.7M trimmed.

  • Invenomic Capital Management's largest Q3 2025 buy was Cedar Fair: 1,034,288 shares worth $23.5M.
  • Invenomic Capital Management added most to Haemonetics in Q3 2025, an estimated $29.1M increase.
  • Invenomic Capital Management's biggest Q3 2025 reduction was Warner Bros, cutting an estimated $20.7M.
  • Invenomic Capital Management fully exited Advance Auto Parts in Q3 2025, selling an estimated $29.3M.
  • Invenomic Capital Management's ten largest holdings make up 27% of its $2.07B portfolio in Q3 2025.
  • Invenomic Capital Management opened 38 new positions and closed 43 in Q3 2025.
  • Invenomic Capital Management's portfolio value rose 17% quarter-over-quarter to $2.07B.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.